New medication approved by FDA for OFF symptoms

Posted on by Phil Franchina

Kynmobi Sunovion Pharmaceuticals announced that the Food and Drug Administration (FDA) approved Kynmobi® (apomorphine hydrochloride), a new sublingual medication...see more for fast relief of OFF symptoms of Parkinson’s disease (PD). Apomorphine acts as a dopamine agonist, mimicking the effects of dopamine in the brain. It was previously only available as Apokyn, an injectable medication that provides […]

Read More

New drug approved for OFF episodes

Posted on by Phil Franchina

Today, Neurocrine Biosciences announced that the Food and Drug Administration (FDA) approved ONGENTYS ® (opicapone), a new medication for...see more treatment of Parkinson’s disease (PD). Opicapone is a catechol-O-methyltransferase (COMT) inhibitor to be used once-daily as an add-on treatment to levodopa for patients who are experiencing OFF time with their current medication regimen. Opicapone is in […]

Read More

New online programs! Register today!

Posted on by Phil Franchina

APDA created two new educational series to help keep you informed, motivated and connected while at home. New dates...see more are being added, so keep checking back. We hope you will join us. Dr. Gilbert Hosts:  Dr. Rebecca Gilbert hosts informative Q&A sessions with various experts via Zoom. Each session features a discussion with the experts, […]

Read More

New online programs! Register today!

Posted on by Phil Franchina

APDA created two new educational series to help keep you informed, motivated and connected while at home. New dates...see more are being added, so keep checking back. We hope you will join us. Dr. Gilbert Hosts:  Dr. Rebecca Gilbert hosts informative Q&A sessions with various experts via Zoom. Each session features a discussion with the experts, […]

Read More

CORONAVIRUS DISEASE 2019 AND THE PD COMMUNITY

Posted on by Phil Franchina

APDA COVID-19 INFORMATION & RESOURCES: The American Parkinson Disease Association (APDA) continues to monitor the COVID-19 situation, particularly as...see more it relates to our Parkinson’s disease (PD) community. This page is updated regularly as new information becomes available. Vaccines: Three COVID-19 vaccines have been approved for use in the United States — one manufactured by Pfizer/BioNTech, […]

Read More

What’s Happening at APDA

Posted on by Phil Franchina

South Florida Symposium Success: APDA’s South Florida Chapter hosted the 5th Annual Parkinson’s Symposium: A...see more Comprehensive Approach to PD in Boca Raton this January. Approximately 250 participants heard from experts including keynote speaker Dr. Carlos Singer, Professor of Neurology, Director of the Division of PD & Movement Disorders, University of Miami […]

Read More